InsiderTrades

Form 4 for RIME Algorhythm Holdings, Inc.

Accepted 2026-05-13 16:30:23 ET · period of report 2026-05-11 · accession 0001493152-26-022750 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-05-13 16:30 2026-05-11 RIME Andre Alex CFO, GC D - Sale to Iss $0.00 -23.8K 0 -100% $0
D 2026-05-13 16:30 2026-05-11 RIME Andre Alex CFO, GC D - Sale to Iss $0.00 +23.8K 210.0K +13% $0
D 2026-05-13 16:30 2026-05-11 RIME Andre Alex CFO, GC A - Grant $0.00 +47.6K 257.6K +23% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-05-11 D D 23,818 $0.00 0 D — — (F1) The reported transaction involved the cancellation of the Reporting Person's previously granted restricted stock award for 23,818 shares of the Issuer's common stock.
2 Derivative Stock Option (right to buy) 2026-05-11 D A 23,818 $0.00 209,973 D $2.78 · — to 2036-02-23 23,818 Common Stock (F2) The reported transaction involved the cancellation of the Reporting Person's previously granted non-qualified stock option to purchase 23,818 shares of the Issuer's common stock. (F4) Twenty-five percent (25%) of the total number of shares subject to the non-qualified stock option shall vest and become exercisable on the first anniversary of the grant date and six and one-quarter percent (6.25%) of the remaining shares shall vest and become exercisable each quarter thereafter.
3 Derivative Stock Option (right to buy) 2026-05-11 A A 47,636 $0.00 257,609 D $0.76 · — to 2036-05-11 47,636 Common Stock (F3) The reported transaction involved the Reporting Person's receipt of a non-qualified stock option to purchase 47,636 shares of the Issuer's common stock. The options were granted pursuant to the Algorhythm Holdings, Inc. 2022 Equity Incentive Plan. (F5) A total of 14,636 shares vested in full on the grant date and a total of 3,666.667 shares vest each quarter thereafter.